Table 1.
Baseline patient demographics and tumor characteristics for surgery and BPCRT cohorts
| Surgery (n=7,276) | Bladder preservation (n=1,178) | P-value | ||
|---|---|---|---|---|
| Age at Diagnosis (median) | 67.39 | 75.21 | <.001 | |
| Sex | Male | 5499 (75.58) | 863 (73.26) | 0.087 |
| Female | 1777 (24.42) | 315 (26.74) | ||
| Treatment Facility Type | Community Cancer Program | 531 (7.33) | 170 (14.44) | <.001 |
| Comprehensive Community Cancer Program | 2648 (36.56) | 617 (52.42) | ||
| Academic/Research Program | 3591 (49.59) | 303 (25.74) | ||
| Integrated Network Cancer Program | 438 (6.05) | 86 (7.31) | ||
| Other specified types of cancer programs | 34 (0.47) | 1 (0.08) | ||
| Charlson-Deyo Score | 0 | 5054 (69.46) | 773 (65.62) | 0.002 |
| 1 | 1722 (23.67) | 294 (24.96) | ||
| 2 | 500 (6.87) | 111 (9.42) | ||
| Primary site | Trigone of bladder | 444 (6.1) | 71 (6.03) | <.001 |
| Dome of bladder | 258 (3.55) | 55 (4.67) | ||
| Bladder wall | 2016 (27.71) | 360 (30.56) | ||
| Bladder neck and ureteric orifice | 237 (3.26) | 62 (5.26) | ||
| Bladder NOS | 4321 (59.39) | 630 (53.48) | ||
| Grade | Well differentiated/Moderately differentiated | 196 (2.98) | 42 (3.98) | 0.083 |
| Poorly differentiated/Undifferentiated | 6371 (97.02) | 1012 (96.02) | ||
| T-stage | 2 | 6292 (86.48) | 1045 (88.71) | 0.036 |
| 3 | 984 (13.52) | 133 (11.29) | ||
| Distance from treatment center (median miles) | 16.4 | 7.5 | <.001 |